A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree that has been used in traditional healing in Cameroon to treat a variety of diseases and conditions including cancers and diabetes.
The article, Safety of Kidney Transplantation from Donors with HIV, details findings supporting HIV-to-HIV kidney transplants as safe and just as effective as those using organs from donors without HIV.
Ivan Vujkovic-Cvijin, PhD, is a pioneer in the study of the gut microbiota and the surprising ways these microorganisms living in our digestive tracts affect our overall health. His discoveries have been featured in Nature, Science Translational Medicine, Cell Reports and other top scientific journals.
The supply of healthcare professionals available to provide HIV care continues to decline, even as the need for HIV care and prevention is expected to increase, reports a survey study in the November/December issue of The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.
In a landmark achievement for the fight against HIV, Sweden has attained the critical “95-95-95” target on the path to tackling the disease. Advanced bioinformatics modeling developed by a team from Los Alamos National Laboratory was deployed to track and verify the country’s progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization target.
According to findings from a multicenter study led by Johns Hopkins Medicine and released today in The New England Journal of Medicine (NEJM), transplanting kidneys from deceased donors who had the human immunodeficiency virus (HIV) to recipients with HIV is safe. Perhaps more importantly, the study authors also found that HIV-to-HIV kidney transplants are comparable in effectiveness to those using organs from donors without HIV.
Experts in infection prevention and control available for interview about research findings and other breaking health topics including the flu, COVID, HIV, mpox, West Nile, and vaccinations
In a new paper published on October 9 in the New England Journal of Medicine, experts are urging all sectors of the health care community to urgently evolve their approaches to meet the continuing HIV/AIDS crisis among Latinos. This call-to-action comes at a time when the decades-long effort to end the epidemic in the U.S. is showing overall progress.
En un nuevo artículo de investigación publicado {hoy/esta semana} en la revista médica New England Journal of Medicine, los expertos en el tema recomiendan encarecidamente que todos los sectores de la comunidad de atención de la salud actualicen sus enfoques para poder enfrentar la crisis permanente del VIH/SIDA en la población latina. Este llamado a la acción surge en un momento en el que se refleja un progreso general en el esfuerzo realizado por varias décadas para erradicar la epidemia en los Estados Unidos.
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news.
Essex County data show that HIV patients maintained their health with remote care during the COVID-19 pandemic.
Experts at the François-Xavier Bagnoud Center at the Rutgers School of Nursing discuss how PrEP medication can help lower HIV infections
Prof. Vincent Guilamo-Ramos, PhD RN Executive Director of the Institute for Policy Solutions (IPS) at Johns Hopkins School of Nursing, joined a diverse group of leaders at the White House today to shine the spotlight on the largely invisible HIV crisis in the Latino community.
With data from extensive genomic surveys of the syphilis bacterium – correlated with clinical information from patients – an international team of researchers and doctors are on the hunt for proteins on the surface of the microbe that don’t vary and could be good targets for a much-needed vaccine
Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.
Dr. Maria Alcaide started her career at the University as an infectious disease physician and has since built a strong research portfolio. She was tapped to be the interim vice provost for research and scholarship.
Researchers at Université de Montréal’s teaching hospital say the discovery could help lessen and even eliminate viral loads in people undergoing antiretroviral therapy.
In a study of 12 participants, researchers at Beth Israel Deaconess Medical Center (BIDMC) have demonstrated that a cocktail of three broadly neutralizing antibodies (bNAb) successfully suppressed virus in people living with HIV. A subset of participants also demonstrated long-term control of the virus months after antibody levels declined to low or undetectable.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right